These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 10655330)

  • 1. A comparison of three GnRH analogues in an IVF programme.
    Weissman A; Barash A
    Hum Reprod; 2000 Feb; 15(2):493-5. PubMed ID: 10655330
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: a prospective randomized study.
    Dada T; Salha O; Baillie HS; Sharma V
    Hum Reprod; 1999 Feb; 14(2):288-93. PubMed ID: 10099965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing assisted reproduction: impact of low-dose gonadotropin-releasing hormone agonist on in vitro fertilization outcome.
    Lenton E; Mohamed K
    Fertil Steril; 2005 Dec; 84(6):1783-5. PubMed ID: 16359992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: a prospective study.
    El-Nemr A; Bhide M; Khalifa Y; Al-Mizyen E; Gillott C; Lower AM; Al-Shawaf T; Grudzinskas JG
    Eur J Obstet Gynecol Reprod Biol; 2002 Jul; 103(2):140-5. PubMed ID: 12069736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the intensity of downregulation on outcome of in vitro fertilization and embryo transfer.
    Lam PM; Cheung LP; Choy CM; Lau YP; Haines C
    Gynecol Endocrinol; 2002 Apr; 16(2):143-50. PubMed ID: 12012625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat.
    Mizutani T; Sakata M; Terakawa N
    Int J Fertil Menopausal Stud; 1995; 40(2):106-11. PubMed ID: 7599657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nafarelin acetate for pituitary down-regulation in in vitro fertilization. Comparison of two dosages.
    Yuzpe AA; Nisker JA; Kaplan BR; Tummon IS; Auckland J
    J Reprod Med; 1995 Feb; 40(2):83-8. PubMed ID: 7738933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nafarelin versus leuprolide in ovulation induction for in vitro fertilization: a randomized clinical trial.
    Penzias AS; Shamma FN; Gutmann JN; Jones EE; DeCherney AH; Lavy G
    Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):739-42. PubMed ID: 1533022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between nafarelin acetate and D-Trp6-LHRH for temporary pituitary suppression in in vitro fertilization (IVF) patients: a prospective crossover study.
    Tanos V; Friedler S; Shushan A; Strauss N; Hetsroni I; Lewin A
    J Assist Reprod Genet; 1995 Nov; 12(10):715-9. PubMed ID: 8624429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization.
    Morgia F; Sbracia M; Schimberni M; Giallonardo A; Piscitelli C; Giannini P; Aragona C
    Fertil Steril; 2004 Jun; 81(6):1542-7. PubMed ID: 15193474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of endometrial thickness as a predictor of pituitary down-regulation after gonadotropin-releasing hormone analogue administration in an in vitro fertilization program.
    Barash A; Weissman A; Manor M; Milman D; Ben-Arie A; Shoham Z
    Fertil Steril; 1998 Mar; 69(3):496-9. PubMed ID: 9531885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of buserelin and nafarelin in IVF cycles and in subsequent frozen-thawed embryo transfer cycles.
    Simberg N; Tulppala M; Husa LM; Tiitinen A
    Acta Obstet Gynecol Scand; 1998 Sep; 77(8):854-9. PubMed ID: 9776601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian estradiol production in vivo. Inhibitory effect of leuprolide acetate.
    Kowalik A; Barmat L; Damario M; Liu HC; Davis O; Rosenwaks Z
    J Reprod Med; 1998 May; 43(5):413-7. PubMed ID: 9610463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ovary stimulation with IVF in women with polycytstic ovary syndrome].
    Hedon B
    J Gynecol Obstet Biol Reprod (Paris); 2003; 32(3 Pt 2):S36-40. PubMed ID: 12773917
    [No Abstract]   [Full Text] [Related]  

  • 16. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.
    Orvieto R; Meltzer S; Rabinson J; Zohav E; Anteby EY; Nahum R
    Fertil Steril; 2008 Oct; 90(4):1294-6. PubMed ID: 18178197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH agonists and in vitro fertilization.
    Barlow DH
    J Reprod Med; 1998 Mar; 43(3 Suppl):245-51. PubMed ID: 9564657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of gonadotropin-releasing hormone agonist (GnRH-a) dipherelin 3,75 mg for in vitro fertilization program].
    Khonelidze N; Tsagareishvili G; Koiava M; Osidze K
    Georgian Med News; 2005 Apr; (121):19-22. PubMed ID: 15908717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of pituitary down-regulation and ovarian response to controlled stimulation in in vitro fertilization cycles.
    Mohamed KA; Davies WA; Lashen H
    Fertil Steril; 2007 Feb; 87(2):433-5. PubMed ID: 17094983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nafarelin acetate for pituitary suppressions in in-vitro fertilisation cycles--a Singaporean experience.
    Loh SK; Leong NK
    Singapore Med J; 1999 Dec; 40(12):752-5. PubMed ID: 10709427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.